ArticleScientific reports2016

Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.

Petra Mulder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.